NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/15/2023
Back to search
Official data from USPTO
NS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NS PHARMA
ST13
US500000087232584Class
5, 42, 45
Filing
87232584
Registration
5362697
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/15/2023
Trademark type
Word
Nice classes
5, 42, 45
Filing date
11/10/2016
Registration date
12/26/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Kyoto-shi, Kyoto, JP
Examiner
HOPKINS, SARAH
Law office
N50
Holders and representatives
Holders
Nippon Shinyaku Co., Ltd.
Representatives
Suzue Fujimori AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and pharmaceutical preparations for the treatment of myelofibrosis and muscular dystrophyboth prescription and over-the-counterfor use in connection with humans
Class 42
Testinganalysisevaluation of pharmaceutical products; development and evaluation of pharmaceutical test methods; consulting services in the field of testinganalysis and research of pharmaceutical products
Class 45
Consulting services relating to regulatory compliance in the pharmaceutical industry; consulting services in the field of pharmaceutical licensing; consulting services in the field of licensing of proprietary technologies in the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
25 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
08/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/15/2023
ES8R
TEAS SECTION 8 RECEIVED
03/13/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/26/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2017
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/06/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/25/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/18/2017
GNRT
NON-FINAL ACTION E-MAILED
08/18/2017
CNRT
NON-FINAL ACTION WRITTEN
08/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2017
ALIE
ASSIGNED TO LIE
07/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2017
GNRT
NON-FINAL ACTION E-MAILED
02/22/2017
CNRT
NON-FINAL ACTION WRITTEN
02/22/2017
DOCK
ASSIGNED TO EXAMINER
02/16/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2016
NWAP
NEW APPLICATION ENTERED
11/14/2016
Continuous trademark protection
Get notified about every new filing that threatens NS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.